Related Experiment Videos
[Apomorphine test in Parkinson disease--dose and corresponding parameters]
M M Pinter1, R J Helscher, A P Sattler
1I. Neurologische Abteilung, Neurologisches Krankenhaus Rosenhügel, Wien.
Wiener Klinische Wochenschrift
|January 1, 1993
Summary
The apomorphine test, used for Parkinson's disease diagnosis, revealed that apomorphine dosage correlates with patient factors and L-dopa amounts. This finding aids in optimizing dopaminergic therapy for Parkinson's patients.
Area of Science:
- Neurology
- Pharmacology
Context:
- The apomorphine test is crucial for assessing dopaminergic therapy response and diagnosing idiopathic Parkinson's disease.
- Understanding patient-specific factors influencing drug response is vital for effective Parkinson's management.
Purpose:
- To investigate the relationship between apomorphine dosage and patient parameters (age, height, weight, disease duration, subcutaneous fat) in Parkinson's disease.
- To determine if varying apomorphine doses significantly alter these patient parameters.
Summary:
- A study of 45 Parkinson's disease patients with positive apomorphine tests found correlations between apomorphine dosage and parameters like age, disease duration, and L-dopa dosage.
- These correlations were statistically significant (p < 0.05), indicating apomorphine dose influences measured patient characteristics.
Impact:
- The findings suggest that apomorphine dosage can serve as an indicator for optimizing L-dopa dosage in Parkinson's disease.
- This research supports personalized treatment strategies, potentially improving intermittent or continuous apomorphine administration protocols.